Is low-dose trazodone (25–50 mg) more effective for treating insomnia in adults?

Trazodone at Lower Doses is NOT More Beneficial for Sleep

The 2019 VA/DoD guidelines explicitly advise AGAINST using trazodone for chronic insomnia disorder at any dose, as the low-quality evidence supporting its efficacy is outweighed by its adverse effect profile 1. This represents the most authoritative and recent guideline-level recommendation.

Why Trazodone Should Be Avoided for Insomnia

Guideline Evidence Against Trazodone

The 2019 VA/DoD systematic review found that trazodone (50-150 mg) showed:

• No difference in sleep efficiency compared to placebo
• No difference in sleep onset latency, total sleep time, or wake after sleep onset
• Only improved subjective sleep quality (not objective measures)
• Studies were very short duration (mean 1.7 weeks) with limited follow-up (1-4 weeks) 1

The 2017 American Academy of Sleep Medicine guideline similarly suggests clinicians NOT use trazodone (50 mg doses studied) for sleep onset or maintenance insomnia, based on weak evidence 2.

FDA Labeling Context

Trazodone is FDA-approved only for major depressive disorder, not insomnia 3. The FDA label warns of significant risks including:

• Orthostatic hypotension and syncope 3
• Increased bleeding risk 3
• Priapism (requiring emergency intervention if erection >4 hours) 3
• Cognitive and motor impairment 3
• Hyponatremia, particularly in elderly 3

The Dose Question: Does Lower Equal Better?

Research Evidence on Low-Dose Trazodone

While guidelines advise against trazodone, research studies suggest a paradoxical finding about dosing:

Lower doses (25-75 mg) may actually be MORE effective than higher doses:

• A 2015 retrospective study found 25 mg trazodone corresponded to the highest percentage of responders (37.93%), with 100% response rates at 25-75 mg versus only 42.85% at 100-150 mg (p<0.001) 4
• Low doses (25-100 mg) showed efficacy in specialized populations like myasthenia gravis patients 5
• A 2017 systematic review noted that since the 2000s, low-dose trazodone (<100 mg) has been increasingly used for insomnia 6

Mechanism: At 25-75 mg, trazodone primarily acts as a 5-HT2 receptor antagonist promoting sleep, with minimal anticholinergic effects. Higher doses add antidepressant mechanisms that may paradoxically worsen sleep architecture 7, 8.

What Trazodone Actually Does to Sleep

Positive effects:

• Increases deep sleep (N3/slow-wave sleep) duration 7
• Reduces number of awakenings 9
• Effective for sleep maintenance insomnia 7

Limitations:

• Less effective for sleep onset (needs to be taken 1+ hours before bedtime) 7
• No improvement in objective sleep efficiency in most studies 9
• Primarily improves subjective sleep quality perception 9

Clinical Algorithm: When Trazodone Might Be Considered Despite Guidelines

First-line approach (per guidelines):

1. Cognitive behavioral therapy for insomnia (CBT-I) 1
2. If pharmacotherapy needed: Low-dose doxepin (3-6 mg) or non-benzodiazepine BZRAs (zolpidem, eszopiclone) 1

Trazodone consideration (off-guideline) only if:

• Patient has comorbid depression requiring antidepressant treatment AND insomnia 10
• Patient has failed or cannot tolerate approved hypnotics 6
• Primary complaint is sleep maintenance (frequent awakenings), not sleep onset 7
• Patient is taking activating antidepressants (SSRIs/SNRIs) causing insomnia 7

If using trazodone despite guidelines:

• Start at 25 mg, taken 1-2 hours before bedtime 4, 8
• Maximum effective dose typically 25-75 mg 4, 8
• Do NOT exceed 100 mg for insomnia (higher doses less effective and more side effects) 4
• Screen for priapism risk factors (sickle cell, anatomical penile abnormalities) 3
• Monitor orthostatic blood pressure, especially in elderly 3
• Reassess after 4 weeks; if ineffective, discontinue rather than increase dose 4

Critical Pitfalls to Avoid

1. Do not use trazodone as first-line for primary insomnia - Guidelines explicitly recommend against this 1, 2
2. Do not escalate doses above 75 mg for insomnia - Higher doses are paradoxically less effective 4
3. Do not ignore priapism warnings - This is a urological emergency requiring immediate discontinuation 3
4. Do not use in elderly without fall risk assessment - Orthostatic hypotension risk is significant 3
5. Do not assume "low dose = safe" - Even 25 mg carries risks of hypotension, bleeding (especially with anticoagulants), and cognitive impairment 3

The Bottom Line

While lower doses of trazodone (25-75 mg) appear more effective than higher doses for insomnia based on research evidence, the fundamental recommendation remains to avoid trazodone for insomnia treatment per authoritative 2019-2020 guidelines 1, 2. The evidence supporting its efficacy is weak, limited to subjective improvements, and outweighed by adverse effects. If used off-guideline in specific clinical scenarios (comorbid depression, failed alternatives), keep doses at 25-75 mg maximum, as higher doses demonstrate paradoxically worse outcomes.